Ambiguous results of an attempt to withdraw barbiturates in epilepsy patients with intellectual disability Bernd Huber, M. Bocchicchio, I. Hauser, V. Horstmann, G. Jokeit, T. May, T. Meinert, E. Robertson, H. Schorlemmer, L. Schulz, W. Wagner, M. Seidel Seizure - European Journal of Epilepsy Volume 18, Issue 2, Pages 109-118 (March 2009) DOI: 10.1016/j.seizure.2008.07.006 Copyright © 2008 British Epilepsy Association Terms and Conditions
Fig. 1 Overview. Seizure - European Journal of Epilepsy 2009 18, 109-118DOI: (10.1016/j.seizure.2008.07.006) Copyright © 2008 British Epilepsy Association Terms and Conditions
Fig. 2 PB serum concentrations in history (N=85, the taper group). *15: around 15=12.5–17.5; *20: around 20=17.5–22.5: around 25: 22.5–27.5μg/ml, etc. Grey/striped columns: long-run/maximum PB serum concentration in history. Seizure - European Journal of Epilepsy 2009 18, 109-118DOI: (10.1016/j.seizure.2008.07.006) Copyright © 2008 British Epilepsy Association Terms and Conditions